Jacobs Levy Equity Management’s Entrada Therapeutics TRDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.48M Buy
220,736
+9,863
+5% +$66.3K 0.01% 683
2025
Q1
$1.91M Sell
210,873
-1,844
-0.9% -$16.7K 0.01% 669
2024
Q4
$3.68M Buy
212,717
+10,914
+5% +$189K 0.01% 482
2024
Q3
$3.22M Buy
201,803
+67,559
+50% +$1.08M 0.01% 512
2024
Q2
$1.91M Buy
+134,244
New +$1.91M 0.01% 607